Ultrasound Guided Blockade of the Lumbar Plexus - the Supra Sacral Parallel Shift (SSPS)

January 30, 2013 updated by: Thomas F. Bendtsen, University of Aarhus

The Supra Sacral Parallel Shift (SSPS) - Ultrasound Guided Blockade of the Lumbar Plexus

Anesthesia for hip surgery can be performed with ultrasound guided blockade of the mesh of nerves (the lumbar plexus) supplying the hip region from the lumbar spinal nerves. This is a relevant technique in patients with severe cardiac comorbidity. The technique is a safer alternative compared to general or spinal anesthesia in these fragile patients.

The most recognized technique with ultrasound guidance (Karmakars technique) is technically demanding and based on injection of local anesthetic relatively close to the exit of the spinal nerves from the spine. The risk is spread of local anesthetic to the spinal canal prompting a risk of low blood pressure. This may be fatal in high risk patients.

The investigators have developed a simple technique based on injection away from the spinal canal. The investigators expect minimal risk of spread of local anesthetic to the spinal canal with this technique.

This randomized, double blinded trial compares the new technique to the established technique of ultrasound guided blockade of the lumbar plexus.

The hypothesis is that the new technique has a higher success rate with reduced effect on blood pressure for ultrasound guided lumbar plexus block compared to the established technique.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aarhus, Denmark, 8000
        • Department of Anesthesiology, Aarhus University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • written informed consent
  • ASA I (American Society of Anesthesiologists physical status classification)

Exclusion Criteria:

  • volunteers who are not able to cooperate
  • volunteers who do not understand and speak danish
  • daily use of analgesics
  • allergy to local analgesics or contrast agents
  • abuse of medicine or alcohol
  • volunteers with technical impediments of the planned interventions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Lumbar ultrasound trident (LUT)
Lumbar plexus block using LUT technique
Lumbar plexus block guided by ultrasound and nerve stimulation with the patient in the lateral position and the probe in the parasagittal plane inserting the block needle between the transverse processes of L3 and L4 until an appropriate neuromuscular response is produced.
Experimental: Supra Sacral Parallel Shift (SSPS)
Lumbar plexus block using SSPS technique
Lumbar plexus block guided by ultrasound and loss of resistance (LOR) with the patient in the lateral position and the probe in the parasagittal plane inserting the block needle between the transverse process of L5 and the sacral bone until an appropriate LOR is produced.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Success of complete sensory blockade of dermatomes L2, L3, L4, L5, S1
Time Frame: 30 minutes after injection of local anesthetic
30 minutes after injection of local anesthetic

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plasma lidocaine level (mcg/mL)
Time Frame: 0, 5, 10, 20, 40, 60, and 90 minutes after injection of local anesthetic
Chromatography analysis
0, 5, 10, 20, 40, 60, and 90 minutes after injection of local anesthetic
Block performance time
Time Frame: From start of probe on the skin until injection of local anesthetic is completed
From start of probe on the skin until injection of local anesthetic is completed
Patient satisfaction
Time Frame: Immediately after completion of injection of local anesthetic
Immediately after completion of injection of local anesthetic
Mean arterial blood pressure (MAP)
Time Frame: 5 minutes after completion of injection of local anesthetic
Absolute measure and relative change from pre-block measure
5 minutes after completion of injection of local anesthetic
Cost-effectiveness
Time Frame: Block performance time period
Estimated as incremental cost-effectiveness ratio
Block performance time period
Sensory blockade of each dermatome L1, L2, L3, L4, L5, S1, S2, and S3 (cold, warmth, touch, pain)
Time Frame: 30 minutes after completed injection of local anesthetic
30 minutes after completed injection of local anesthetic
Sensory blockade of the femoral nerve (cold, warmth, touch, pain)
Time Frame: 30 minutes after completion of injection of local anesthetic
30 minutes after completion of injection of local anesthetic
Motor blockade of the femoral nerve
Time Frame: 40 minutes after completion of injection of the local anesthetic
40 minutes after completion of injection of the local anesthetic
Motor blockade of the obturator nerve
Time Frame: 40 minutes after completion of injection of the local anesthetic
40 minutes after completion of injection of the local anesthetic
Perineural spread of local anesthetic (with contrast) estimated with MRI
Time Frame: 60 minutes after completion of injection of local anesthetic
60 minutes after completion of injection of local anesthetic

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Else Tønnesen, Professor, Faculty of Health, Aarhus University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

August 16, 2012

First Submitted That Met QC Criteria

August 17, 2012

First Posted (Estimate)

August 20, 2012

Study Record Updates

Last Update Posted (Estimate)

January 31, 2013

Last Update Submitted That Met QC Criteria

January 30, 2013

Last Verified

January 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • SSPS-1-10-72-366-12

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fracture

Clinical Trials on Lumbar plexus block using LUT technique

Subscribe